Adaptimmune Therapeutics plc (ADAP)

NASDAQ: ADAP · IEX Real-Time Price · USD

1.075

+0.015 (1.42%)

At close: Apr 26, 2024, 4:00 PM

1.090

+0.015 (1.40%)

After-hours: Apr 26, 2024, 7:36 PM EDT

Adaptimmune Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	244	180	239	586	834	126	601	626	287
Market Cap Growth	-	-24.70%	-59.17%	-29.79%	561.07%	-79.01%	-3.92%	118.30%	-
Enterprise Value	119	55	56	240	485	58	392	413	101
PE Ratio	-1.58	-1.58	-1.45	-3.71	-6.41	-0.92	-6.30	-8.93	-4.01
PS Ratio	4.05	2.99	8.81	95.28	210.82	112.50	10.11	16.55	20.20
PB Ratio	6.18	4.56	2.92	2.85	2.44	1.02	2.44	3.08	1.73
P/FCF Ratio	-1.24	-1.24	-1.40	271.87	-14.92	-1.11	-5.55	-7.98	-4.81
P/OCF Ratio	-1.28	-1.28	-1.69	54.61	-15.57	-1.12	-5.76	-11.52	-5.95
EV/Sales Ratio	1.98	0.92	2.07	39.04	122.62	51.38	6.59	10.93	7.13
EV/EBITDA Ratio	-0.54	-0.54	-0.36	-1.59	-3.97	-0.45	-4.50	-6.43	-1.50
EV/EBIT Ratio	-0.49	-0.49	-0.34	-1.53	-3.74	-0.42	-4.13	-5.93	-1.43
EV/FCF Ratio	-0.38	-0.38	-0.33	111.39	-8.68	-0.51	-3.62	-5.27	-1.70
Debt / Equity Ratio	0.64	0.64	0.28	0.12	0.07	0.21	-	-	-
Debt / EBITDA Ratio	-0.25	-0.25	-0.15	-0.17	-0.19	-0.20	-	-	-
Debt / FCF Ratio	-0.17	-0.17	-0.13	11.82	-0.42	-0.22	-	-	-
Quick Ratio	2.07	2.07	3.31	5.95	9.55	2.74	8.57	2.86	4.64
Current Ratio	2.85	2.85	3.96	6.64	10.19	3.51	9.46	3.10	4.93
Asset Turnover	0.20	0.20	0.07	0.02	0.01	0.01	0.23	0.13	0.06
Return on Equity (ROE)	-134.70%	-134.70%	-132.30%	-61.20%	-39.70%	-80.90%	-43.40%	-32.30%	-37.60%
Return on Assets (ROA)	-37.60%	-37.60%	-45.00%	-38.90%	-30.10%	-61.00%	-36.60%	-24.80%	-29.90%
Return on Capital (ROIC)	-215.82%	-215.82%	-156.22%	-70.11%	-36.56%	-93.74%	-33.36%	-39.74%	-43.82%
Earnings Yield	-46.63%	-63.21%	-69.16%	-26.98%	-15.59%	-108.67%	-15.88%	-11.21%	-24.96%
FCF Yield	-59.61%	-80.80%	-71.59%	0.37%	-6.70%	-90.39%	-18.01%	-12.53%	-20.81%
Buyback Yield / Dilution	-24.73%	-24.73%	-3.47%	-9.36%	-35.72%	-7.78%	-10.75%	-24.23%	-97.81%
Total Shareholder Return	-24.73%	-24.73%	-3.47%	-9.36%	-35.72%	-7.78%	-10.75%	-24.23%	-97.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).